Upload Avatar (500 x 500)
Shengying Qin
Life Science
Shanghai Jiao Tong University
Shanghai
Language: Chinese, English
Pharmacogenomics
Personalized Medicine
Birth Defects
Disease Genomics
Molecular Markers
Drug Response
Molecular Mechanisms
High-Throughput Technologies
Disease Treatment
Precision Medicine
Areas of Focus
- Pharmacogenomics and Personalized Medicine
- Birth Defects and Disease Genomics
Work Experience
- Current - Director at Bio-X Institutes, Shanghai Jiao Tong University
- 2014-2015 - Visiting Scholar at Harvard University and Broad Institute
Academic Background & Achievements
- 2005 - PhD from Shanghai Jiao Tong University
- 2014-2015 - Visiting Scholar at Harvard University and Broad Institute
- Director at Bio-X Institutes, Shanghai Jiao Tong University
Publications
- Improving polygenic prediction in ancestrally diverse populations, Shengying Qin et al., 2022
- Multi-omics analysis identifies rare variation in leptin/PPAR gene sets and hypermethylation of ABCG1 contribute to antipsychotics-induced metabolic syndromes, Shengying Qin et al., 2022
- MiR143-3p-mediated neuregulin-1-dependent mitochondrial dysfunction contributes to olanzapine resistance in refractory schizophrenia, Shengying Qin et al., 2022
Awards
- International Human Genetics Society Young Researcher Award
- Second Prize in National University Biology Micro-course Competition
- SMC Excellent Young Teacher Award at Shanghai Jiao Tong University
- First Prize in Outstanding Postdoctoral Award Fund
